![Athanasios Tsiatis](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Athanasios Tsiatis
Teknisk/Vetenskaplig/F&U Direktör på
ALX ONCOLOGY HOLDINGS INC.
Profil
Athanasios Tsiatis currently works at ALX Oncology Holdings, Inc., as Senior Vice President-Clinical Development from 2021.
Dr. Tsiatis also formerly worked at Plexxikon, Inc., as Vice President-Clinical Development from 2020 to 2021.
Dr. Tsiatis received his undergraduate degree from New York University and doctorate degree from Vanderbilt University School of Medicine.
Aktiva positioner av Athanasios Tsiatis
| Företag | Position | Start |
|---|---|---|
| ALX ONCOLOGY HOLDINGS INC. | Teknisk/Vetenskaplig/F&U Direktör | 2021-11-01 |
Tidigare kända positioner av Athanasios Tsiatis
| Företag | Position | Slut |
|---|---|---|
Plexxikon, Inc.
 Plexxikon, Inc. Miscellaneous Commercial ServicesCommercial Services Provides clinical and medical drug discovery and development services | Teknisk/Vetenskaplig/F&U Direktör | 2021-11-01 |
Athanasios Tsiatiss utbildningar
Erfarenheter
Innehade positioner
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Relationer
26
Första gradens relationer
4
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
Kopplade företag
| Privata företag | 4 |
|---|---|
Plexxikon, Inc.
Plexxikon, Inc. Miscellaneous Commercial ServicesCommercial Services Provides clinical and medical drug discovery and development services | Commercial Services |
New York University
 New York University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Vanderbilt University School of Medicine
 Vanderbilt University School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
ALX Oncology Holdings, Inc.
 ALX Oncology Holdings, Inc. BiotechnologyHealth Technology Operates as clinical stage immuno-oncology company, which develops therapies for cancer | Health Technology |
